Health. Innovation. Experience.

We operate at the intersection of public policy, business strategy, and government affairs.

Healthsperien, LLC, is a nationally-recognized health care policy consulting firm focused on federal and state regulatory and legislative policy analysis, advocacy, and implementation issues.

Our mission is to accelerate responsible and sustainable health care system innovation and transformation to improve health outcomes for all, and especially the most vulnerable.

Our team serves clients at the intersection of public policy, business strategy, and government affairs, and we are dedicated to helping organizations navigate the complexities and challenges of health care policy, politics, and regulation.

Featured News & Resources

Weekly Roundup: January 20, 2023

Inside this Edition Healthsperien Releases Summary on 2024 Medicare Advantage and Part D Proposed Rule | FDA Rejects Eli Lilly’s Request for Accelerated Approval for Alzheimer’s Drug | SAMHSA Releases Guide on Behavioral Health Services for People Experiencing Homelessness | Executive Action | Congressional Action | Medicare  | Research Our team of experts at Healthsperien are proactively working to support your organization’s …

Just Released – Healthsperien Develops Comprehensive Summary of 2024 Medicare Advantage and Part D Proposed Rule

Last month in December, CMS released their annual Medicare Advantage and Part D proposed rule for 2024. Healthsperien developed a comprehensive, section-by-section summary of the proposed rule, covering a wide range of critical topics, including changes to utilization management, Star Ratings, plan marketing, behavioral health, and the Medication Therapy Management program. The rule also proposes several changes to better incorporate …

Weekly Roundup: January 13, 2023

Inside this Edition Top Administration Science Official Stepping Down from COVID Response Team |Improvements in Cancer Treatment and Screening Continue to Shrink Cancer Death Rate | Federal Trade Commission Publishes Proposed Rule to Ban Noncompete Clauses | Administrative Action | Congressional Action | Litigation | Marketplace | Medicare | Medicaid  | Research Our team of experts at Healthsperien are proactively working to support …

Weekly Roundup: December 22, 2022

Inside this Edition Senate Clears $1.7 Trillion Omnibus Spending Package, Sending Legislation to the House |National Association of Medicaid Directors Supports Provisions in Omnibus Package | Rep. Guthrie Makes Price Transparency and Medical Innovation Priorities in Next Congress | Joint Commission to Launch Health Care Equity Certification Program in 2023 | Administrative Action | Congressional Action | Medicare | Medicaid  Our team …

Let's work together

Scroll to Top